Our team

Nurse holding the hand of an elderly personBirmingham ECMC supports the development of innovative early phase studies at the CRUK Clinical Trials Unit. Moreover, we provide funding to key posts within their Early Drug Development team.

Amit Patel - Biostatistician

Amit supports the design and statistical analysis of experimental cancer trials. He is currently contributing to the development of a major new brain cancer platform, the Tessa Jowell Brain Matrix

Ceri Armstrong, Marie Lewis and Faye Lowe - Research Nurses

Ceri, Marie and Faye specialise in early phase cancer trials. They recruit to both University-sponsored trials such as the National Lung Matrix Trial, and to externally-led trials including those involving advanced therapies. They offer invaluable support to patients undertaking early phase trials, and understand the complexities of this experimental research. 

Janet Prentice - Trial Administrator

Janet is part of the nursing team specialising in Early Drug Development Trials. She facilitates the set-up and administration of early phase trials at the University Hospitals Birmingham NHS Foundation Trust (Queen Elizabeth Hospital site).

Senior Trial Co-ordinator

This role drives forward the development of experimental cancer trials, encompassing study protocol and documentation development, site contracting and liaison, and regulatory submissions. 

Our funding also supports the following posts:

Bridget Bell - ECMC Project Manager

Bridget provides oversight and operational support with the delivery of Birmingham ECMC's key strategic objectives and facilitates our involvement in ECMC network initiatives. She collaborates with both the Cancer Research UK Birmingham Centre and the Cancer Research UK Clinical Trials Unit, to support the delivery of shared strategic goals, and promote forward and reverse translation opportunities. 

Dr Anetta Ptasinska - Biomarker Validation Scientist

Working within Professor Andrew Beggs' Genomics Birmingham laboratory, Anetta undertakes whole genome sequencing, including reviewing the TSA500 panel, which we use to match patients with experimental trials. She has extensive experience in 10x, single cell analysis and TSO500 panel analysis. 

Dr Saisakul Chernbumroong - Bioinformatician (Research Fellow in AI and Machine Learning) 

Working within the Centre for Computational Biology, Saisakul undertakes projects relating to patient stratification and biomarker development, using machine learning.She is currently investigating potential links between cancer drug responses and patients’ individual genetic make up. This encompasses the impact of single and of combination agents on multiple data types.

We also provide funding to University Hospitals Birmingham, to support their cancer research activity in histopathology, imaging and trials pharmacy.